This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys Balance Sheet Health

Financial Health criteria checks 2/6

MorphoSys has a total shareholder equity of €-261.7M and total debt of €1.7B, which brings its debt-to-equity ratio to -658%. Its total assets and total liabilities are €1.8B and €2.1B respectively.

Key information

-658.0%

Debt to equity ratio

€1.72b

Debt

Interest coverage ration/a
Cash€630.77m
Equity-€261.67m
Total liabilities€2.09b
Total assets€1.83b

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MOR has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: MOR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MOR has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MOR has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.7% each year


Discover healthy companies